Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	150.05B
Revenue (ttm)	10.30B
Net Income (ttm)	3.05B
Shares Out	173.47M
EPS (ttm)	17.59
PE Ratio	49.18
Forward PE	41.23
Dividend	1.20 (0.14%)
Ex-Dividend Date	n/a

Volume	111,697
Average Volume	330,187
Open	872.00
Previous Close	869.65
Day's Range	861.45 - 881.35
52-Week Range	390.40 - 986.00
Beta	n/a
RSI	48.66
Earnings Date	May 30, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 447
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2024, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.